Appointments
ImmunSYS, a Fort Lauderdale, Florida-based firm focused on the development of innovative cancer immunotherapy products, today announced that...
AstraZeneca’s Sean Bohen has announced he will step down from his role as chief medical officer at the Anglo-Swedish drugmaker amid speculation...
Roche subsidiary, Foundation Medicine, today announced the appointment of Roche’s senior vice president in global oncology, Cindy Perettie as the...
bluebird bio, a US-based gene therapy biotech with a focus on cancer and severe genetic conditions, has named Nicola Redfern as the new...
The Anglo-Swedish multinational AstraZeneca has named Dr José Baselga as the firm’s new head of research and development in oncology.
The...
Clinical stage biotechnology company Immunocore has announced the appointment of AstraZeneca executive Bahija Jallal as the company’s new CEO....
The Cambridge, Massachusetts pharma firm Ironwood Pharmaceuticals has announced the appointment of AstraZeneca veteran Mark Mallon in preparation...
Liz Barret, the CEO of Swiss firm Novartis Oncology has said that she is standing down after being in the role for less than a year.
The...
The Dublin-headquartered multinational Allergan has appointed two experienced pharma investors to its Finance Leadership Team.
The...
New York City-based multinational Pfizer has announced the appointment of Ben Osborn to the role of managing Director in the UK and Cluster Lead...